Unknown

Dataset Information

0

Anti-IL-7 receptor-? treatment ameliorates newly established Sjogren's-like exocrinopathy in non-obese diabetic mice.


ABSTRACT: The levels of interleukin (IL)-7 and its receptor are elevated in the salivary glands of patients with Sjögren's syndrome (SS). Our previous study indicates that IL-7 plays a critical pathogenic role in the development and onset of SS in a mouse model of this disease. The present study aims at determining whether IL-7 also plays a role in sustaining SS pathologies after the disease onset, by using the non-obese diabetic (NOD) model. Intraperitoneal administration of a blocking antibody against the IL-7 receptor ? chain (IL-7R?) to female NOD mice aged 10?weeks, which exhibited newly onset clinical SS, for the duration of 3?weeks significantly ameliorated characteristic SS pathologies including hyposalivation and leukocyte infiltration of the submandibular glands (SMGs). These changes were accompanied by a decrease in IFN-?-producing CD4 T- and CD8 T cells, B cells, and lymphocyte chemoattractants CXCL9, -10, -11 and -13 in the SMGs. Anti-IL-7R? treatment markedly diminished the amount of TNF-? in the SMGs and increased the level of claudin-1 and aquaporin 5, two molecules critical for normal salivary secretion. Furthermore, neutralization of IFN-? and TNF-?, individually or in combination, considerably improved salivary secretion, reduced leukocyte infiltration and down-regulated CXCL9 and -13 expression in the SMGs. Collectively, the results indicate that endogenous IL-7R signals promote Th1 and Tc1 responses and IFN-?- and TNF-? production to sustain the persistence of SS-like sialadenitis in NOD mice. These findings suggest that IL-7 and Th1 cytokines could serve as promising therapeutic targets for this prevalent autoimmune disease.

SUBMITTER: Zhou J 

PROVIDER: S-EPMC5963292 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-IL-7 receptor-α treatment ameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice.

Zhou Jing J   Yu Qing Q  

Biochimica et biophysica acta. Molecular basis of disease 20180419 7


The levels of interleukin (IL)-7 and its receptor are elevated in the salivary glands of patients with Sjögren's syndrome (SS). Our previous study indicates that IL-7 plays a critical pathogenic role in the development and onset of SS in a mouse model of this disease. The present study aims at determining whether IL-7 also plays a role in sustaining SS pathologies after the disease onset, by using the non-obese diabetic (NOD) model. Intraperitoneal administration of a blocking antibody against t  ...[more]

Similar Datasets

| S-EPMC3580566 | biostudies-literature
| S-EPMC1954678 | biostudies-literature
| S-EPMC2451047 | biostudies-other
| S-EPMC4152049 | biostudies-literature
| S-EPMC3412026 | biostudies-literature
| S-EPMC3435870 | biostudies-literature
| S-EPMC7408693 | biostudies-literature
| S-EPMC3729733 | biostudies-literature
| S-EPMC3137845 | biostudies-literature
| S-EPMC4127355 | biostudies-literature